Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 114

Published Date: 10 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Group ACYW135 Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Group ACYW135 Meningococcal Polysaccharide Vaccine industry chain, the market status of Hospital (Class I Vaccines, Class II Vaccines), Clinic (Class I Vaccines, Class II Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Group ACYW135 Meningococcal Polysaccharide Vaccine.

Regionally, the report analyzes the Group ACYW135 Meningococcal Polysaccharide Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Group ACYW135 Meningococcal Polysaccharide Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Group ACYW135 Meningococcal Polysaccharide Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Class I Vaccines, Class II Vaccines).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Group ACYW135 Meningococcal Polysaccharide Vaccine market.

Regional Analysis: The report involves examining the Group ACYW135 Meningococcal Polysaccharide Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Group ACYW135 Meningococcal Polysaccharide Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Group ACYW135 Meningococcal Polysaccharide Vaccine:
Company Analysis: Report covers individual Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Group ACYW135 Meningococcal Polysaccharide Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Group ACYW135 Meningococcal Polysaccharide Vaccine. It assesses the current state, advancements, and potential future developments in Group ACYW135 Meningococcal Polysaccharide Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Group ACYW135 Meningococcal Polysaccharide Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Group ACYW135 Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Class I Vaccines
Class II Vaccines

Market segment by Application
Hospital
Clinic

Major players covered
Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Group ACYW135 Meningococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Group ACYW135 Meningococcal Polysaccharide Vaccine from 2019 to 2024.
Chapter 3, the Group ACYW135 Meningococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Group ACYW135 Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Group ACYW135 Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Group ACYW135 Meningococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe Group ACYW135 Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Group ACYW135 Meningococcal Polysaccharide Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Class I Vaccines
        1.3.3 Class II Vaccines
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size & Forecast
        1.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Sanofi-Pasteur
        2.1.1 Sanofi-Pasteur Details
        2.1.2 Sanofi-Pasteur Major Business
        2.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi-Pasteur Recent Developments/Updates
    2.2 Walvax Biotechnology
        2.2.1 Walvax Biotechnology Details
        2.2.2 Walvax Biotechnology Major Business
        2.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Walvax Biotechnology Recent Developments/Updates
    2.3 Chengdu Kanghua Biological Products Co., Ltd
        2.3.1 Chengdu Kanghua Biological Products Co., Ltd Details
        2.3.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
        2.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
    2.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
        2.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Details
        2.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
        2.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
    2.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
        2.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Details
        2.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
        2.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
    2.6 Beijing Institute of Biological Products Co., Ltd
        2.6.1 Beijing Institute of Biological Products Co., Ltd Details
        2.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
        2.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
    2.7 CanSino Biologics AG
        2.7.1 CanSino Biologics AG Details
        2.7.2 CanSino Biologics AG Major Business
        2.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.7.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 CanSino Biologics AG Recent Developments/Updates
    2.8 Yuxi Watson Biotechnology Co., Ltd
        2.8.1 Yuxi Watson Biotechnology Co., Ltd Details
        2.8.2 Yuxi Watson Biotechnology Co., Ltd Major Business
        2.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
    2.9 Hualan Biovaccine Co., Ltd
        2.9.1 Hualan Biovaccine Co., Ltd Details
        2.9.2 Hualan Biovaccine Co., Ltd Major Business
        2.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
    2.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
        2.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Details
        2.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
        2.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
        2.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates

3 Competitive Environment: Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer
    3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
    3.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Region Footprint
        3.5.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
        3.5.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region
        4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
    4.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.5 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
        7.3.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
        8.3.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region
        9.3.1 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
        10.3.1 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
        11.3.1 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
    12.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
    12.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Group ACYW135 Meningococcal Polysaccharide Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Group ACYW135 Meningococcal Polysaccharide Vaccine
    13.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Process
    13.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
    14.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi-Pasteur Major Business
    Table 5. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 6. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Sanofi-Pasteur Recent Developments/Updates
    Table 8. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 9. Walvax Biotechnology Major Business
    Table 10. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 11. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Walvax Biotechnology Recent Developments/Updates
    Table 13. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 14. Chengdu Kanghua Biological Products Co., Ltd Major Business
    Table 15. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 16. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
    Table 18. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 19. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
    Table 20. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 21. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
    Table 23. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 24. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
    Table 25. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 26. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
    Table 28. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 29. Beijing Institute of Biological Products Co., Ltd Major Business
    Table 30. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 31. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
    Table 33. CanSino Biologics AG Basic Information, Manufacturing Base and Competitors
    Table 34. CanSino Biologics AG Major Business
    Table 35. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 36. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. CanSino Biologics AG Recent Developments/Updates
    Table 38. Yuxi Watson Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 39. Yuxi Watson Biotechnology Co., Ltd Major Business
    Table 40. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 41. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
    Table 43. Hualan Biovaccine Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 44. Hualan Biovaccine Co., Ltd Major Business
    Table 45. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 46. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Hualan Biovaccine Co., Ltd Recent Developments/Updates
    Table 48. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Manufacturing Base and Competitors
    Table 49. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
    Table 50. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
    Table 51. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
    Table 53. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 54. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 55. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Group ACYW135 Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 57. Head Office and Group ACYW135 Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
    Table 58. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
    Table 59. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    Table 60. Group ACYW135 Meningococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
    Table 61. Group ACYW135 Meningococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 63. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 64. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 65. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 66. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 67. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 68. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 73. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 74. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 75. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 76. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 79. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 80. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 81. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 82. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 83. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 84. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 85. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 86. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 89. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 90. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 91. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 92. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 93. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 94. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 97. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 98. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 99. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 100. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 101. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 102. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 103. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 104. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 105. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 106. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 107. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 108. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 109. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 110. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 111. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 113. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 114. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 115. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 116. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 117. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 118. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 120. Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Material
    Table 121. Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Materials
    Table 122. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
    Table 123. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
List of Figures
    Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Picture
    Figure 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Class I Vaccines Examples
    Figure 5. Class II Vaccines Examples
    Figure 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
    Figure 73. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
    Figure 74. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2023
    Figure 77. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
    Figure 78. Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd

Related Reports

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2023-2029

date 15 Feb 2023

date Pharma & Healthcare

The global Group ACYW135 Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Pharma & Healthcare

The global Group ACYW135 Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Group ACYW135 Meningococcal Polysaccharide Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>